Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
GSK’s AREXVY Vaccine Shows Promising Results Across Three RSV Seasons
GSK plc (LSE/NYSE: GSK) has released new data from the AReSVi-006 Phase III trial, demonstrating the efficacy and safety of its RSV vaccine, AREXVY, over three full RSV
RSV can be deadly, especially for older adults. What to know about symptoms and the new vaccine
In most cases, adequate hydration and over-the-counter pain relievers can help manage your symptoms during the week or two it takes to recover from RSV. But children under 5 and adults 60 and older are at high risk of severe infection resulting in hospitalization. The latter are also in danger of death.
Pregnant women and older adults eligible for RSV vaccine in Wolverhampton
Wolverhampton Council is encouraging pregnant and older woman to book their appointments for the RSV vaccine ahead of winter.
RSV, Flu and COVID-19 season is here, so do you need three vaccines?
COVID-19, influenza and RSV are the main threats between October and May. There are vaccines for all three viruses, so you may be wondering -- which do you need and can you get them at the same time?
RSV vaccine still 43.3 percent effective 3 years after people take it, trial shows
GSK announced on Tuesday that a single dose of its Arexvy vaccine against respiratory syncytial virus (RSV) was 43.3% effective in preventing severe illness three years after patients 60 and older first received the shot.
What to know about the RSV vaccine ahead of virus season
Dr. Jaunita Mora said the respiratory syncytial virus is the leading cause of infant hospitalizations. Here are the people she said are most vulnerable to the disease.
Making an RSV Vaccine Was Hard. Getting People to Take It Is Even Harder
RSV hospitalizes thousands of people in the US every year. Three new vaccines could help stem the spread, but there are already huge inequities in access and uptake.
9h
on MSN
What you need to know about the RSV Vaccine
The CDC recommends that all individuals aged 75 and older, as well as adults aged 60 and older who are at risk for severe RSV ...
Yahoo
3d
New RSV vaccine guidelines: Adults 75+ urged to vaccinate
AUSTIN (KXAN) — In 2023, the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) ...
6d
GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up
U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...
7d
Low RSV and COVID vaccine usage is in line with investor expectations, but concerning: Jefferies
Low uptake in the RSV and COVID vaccine markets is not surprising, an analyst says, and could mean weak earnings for ...
scrippsnews on MSN
3d
Harnessing Your Health: What you need to know about COVID-19, flu, and RSV for the fall and winter
There’s about 270 different viruses that can infect humans, and in the fall and winter we're inside more where they can ...
6d
GSK RSV shot 43% effective against severe disease in third year
GSK said on Tuesday that its Arexvy respiratory syncytial virus vaccine was 43.3% effective in preventing severe illness in ...
Oxford Mail on MSN
1h
Eligible Oxfordshire residents urged to get free RSV vaccine
Eligible Oxfordshire residents are being encouraged to receive their Respiratory Syncytial Virus vaccine ahead of winter.
cidrap.umn
10h
Study: Natural killer cells determine RSV severity
Researchers from Brigham and Women’s Hospital published new research in Science Translational Medicine showing that natural ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
GSK
GlaxoSmithKline
United States
AREXVY
Covid
Feedback